| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |